Noninvasive Optical Assessment of Implanted Tissue-Engineered Construct Success In Situ

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Optical Spectroscopy

Background:

• Tissue-engineered devices require non-destructive monitoring tools for assessing graft success in vivo.
• Current methods for evaluating implanted tissue constructs are often invasive or lack real-time capabilities.

Purpose of the Study:

• To develop and validate quantitative diffuse reflectance spectroscopy (DRS) as a label-free, noninvasive, and real-time assessment tool for implanted tissue-engineered devices.
• To evaluate the ability of DRS to monitor construct success in situ based on optical properties related to revascularization and cellularity.

Main Methods:

• Quantitative diffuse reflectance spectroscopy (DRS) was applied to human oral keratinocyte constructs implanted in a murine model for 1 and 3 weeks.
• DRS measured optical absorption (hemoglobin, oxygenation) and scattering (cellular density, layer thickness).
• Results were compared with destructive histology and noninvasive preimplantation measures.

Main Results:

• DRS successfully distinguished healthy from stressed constructs at 1 week postimplantation.
• At 3 weeks, DRS identified constructs with higher postimplantation success.
• DRS provided insights into revascularization and construct cellularity, correlating with graft outcomes.

Conclusions:

• Quantitative DRS is a promising, clinically compatible technology for rapid, noninvasive assessment of tissue-engineered constructs in vivo.
• DRS enables localized, real-time monitoring of graft success, addressing a critical need in tissue engineering.
• This technique supports longitudinal monitoring of implanted devices without requiring destructive sampling.